Comparative analysis of carrier systems for delivering bone morphogenetic proteins

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Bone regeneration is crucial for treating skeletal defects.
• Biomaterials combined with growth factors show promise for enhancing bone healing.
• Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a potent osteoinductive factor.

Purpose of the Study:

• To compare the bone regenerative capacity of absorbable collagen sponge (ACS), biphasic calcium phosphate block (BCP), and collagenated biphasic calcium phosphate (CBCP) when loaded with a low dose of rhBMP-2.
• To evaluate the efficacy of different biomaterial carriers for rhBMP-2 in promoting bone formation.
• To assess the dimensional stability and new bone formation in critical-sized defects.

Main Methods:

• Characterization of CBCP using X-ray diffraction and scanning electron microscopy.
• Creation of critical-sized calvarial defects in rabbits.
• Treatment groups included control (blood only), rhBMP-2 loaded ACS, rhBMP-2 loaded BCP, and rhBMP-2 loaded CBCP.
• Histological and histomorphometric analyses at 2 and 8 weeks post-implantation.

Main Results:

• CBCP exhibited web-like collagen fibrils, indicating favorable surface morphology.
• BCP and CBCP demonstrated superior dimensional stability compared to control and ACS groups.
• Significantly greater new bone formation was observed in BCP and CBCP groups at 2 weeks.
• CBCP showed enhanced early bone formation within the defect compared to BCP at 2 weeks.
• No significant differences in bone formation were found among groups at 8 weeks.

Conclusions:

• A low dose of rhBMP-2 effectively enhanced early bone regeneration when delivered via BCP and CBCP scaffolds in rabbit calvarial defects.
• The biomaterial carrier plays a role in the initial phase of bone healing.
• While early advantages were noted for CBCP, long-term bone regeneration appeared comparable across effective carriers.